ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,106Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 315

$841K Total Retail Price of All Prescriptions

Rank: 20 out of 315

592 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 12,207 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
PRAVASTATIN SODIUM 647 614 1 10
AMLODIPINE BESYLATE 525 478 2 2
SIMVASTATIN 502 497 3 1
ATORVASTATIN CALCIUM 371 341 4 5
METOPROLOL SUCCINATE 353 341 5 13
OMEPRAZOLE 320 300 6 9
METOPROLOL TARTRATE 305 280 7 18
WARFARIN SODIUM 275 261 8 20
LOSARTAN POTASSIUM 274 254 9 4
ALLOPURINOL 256 242 10 14
CARVEDILOL 253 238 11 22
COREG CR 251 244 12 131
FUROSEMIDE 249 224 13 15
DIGOXIN 241 218 14 45
PANTOPRAZOLE SODIUM 207 198 15 35
DONEPEZIL HCL 203 203 16 28
RANITIDINE HCL 182 137 17 42
HYDROCHLOROTHIAZIDE 174 168 18 16
LEVOTHYROXINE SODIUM 171 157 19 6
METFORMIN HCL 170 165 20 7
LOSARTAN-HYDROCHLOROTHIAZIDE 157 156 21 17
JANUMET 153 131 22 83
FELODIPINE ER 145 144 23 23
ZETIA 144 144 24 84
NAMENDA 141 140 25 38
TAMSULOSIN HCL 139 126 26 21
BISOPROLOL FUMARATE 138 138 27 119
PLAVIX 138 124 27 40
JANUVIA 132 131 29 31
CRESTOR 129 120 30 24
METFORMIN HCL ER 128 128 31 33
CLOPIDOGREL 121 103 32 25
ATENOLOL 121 113 32 11
HYDROCODONE-ACETAMINOPHEN 119 94 S3 34 19
HYDRALAZINE HCL 114 94 35 98
LISINOPRIL 112 87 36 3
AMLODIPINE-ATORVASTATIN 104 104 10 37 118
LOVASTATIN 102 102 38 8
DIOVAN 93 84 39 27
ALENDRONATE SODIUM 92 92 40 12
LOVAZA 79 75 41 64
LABETALOL HCL 78 70 42 125
ISOSORBIDE DINITRATE 75 65 43 286
ISOSORBIDE MONONITRATE ER 74 71 44 92
POTASSIUM CHLORIDE 73 71 45 36
GLIPIZIDE 65 64 46 30
NEXIUM 64 64 47 54
GLIPIZIDE ER 64 51 47 55
FINASTERIDE 61 61 49 60
SPIRIVA 59 41 50 74
EXFORGE 58 58 51 107
ACTONEL 57 57 52 47
ENALAPRIL MALEATE 55 55 53 86
GLYBURIDE 52 42 R 54 49
SYNTHROID 52 49 54 51
CARBIDOPA-LEVODOPA 50 42 56 136
DIOVAN HCT 50 50 56 56
MUPIROCIN 50 48 56 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.